Search results
Results from the WOW.Com Content Network
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
In 2005, the head office of IBA Group was opened in Prague and at the same time IBA CZ office expanded to include a branch in Brno, Czech Republic. [8] In 2010, an office was opened in Astana . [ 9 ] [ 10 ] In 2012, IBA Ukraine was opened in Kyiv , [ 11 ] and in 2013, IBA South Africa was established in Johannesburg .
In 2010, Quintiles opens new European headquarters in the UK and establishes operations in East Africa. In 2011, Quintiles buys Advion Biosciences, a bioanalytical lab based out of Ithaca, New York. In 2013, Quintiles filed for an IPO on 15 February in order to go public again; Quintiles begins trading on the New York Stock Exchange (NYSE ...
(Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly-owned drug, the health regulator's ...
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific .
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.
Catalent, Inc. (Catalent Pharma Solutions), a subsidiary of Novo Holdings A/S since 2024, is a multinational corporation headquartered in Somerset, New Jersey. It is a provider of drug delivery technologies, drug development , drug manufacturing , biologics , gene therapy , and consumer health products.